What actually changes
Falls become a mortality risk, not an inconvenience
Fall risk rises sharply through this decade and a fall with a fracture is a step change in trajectory rather than a setback. Balance, lower-limb strength and a medication review do more for this than any supplement.
Polypharmacy becomes its own hazard
Prescriptions accumulate, interactions multiply, and drugs started for a good reason a decade ago are rarely reviewed. A structured deprescribing review is one of the few interventions at this age with a plausible net benefit and almost no cost.
Hearing loss is a modifiable dementia risk factor
Untreated hearing loss is among the larger potentially modifiable contributors to dementia risk at a population level. Hearing is easy to test, aids are effective, and uptake is poor because it is treated as cosmetic.
Interventions graded in this group
Nothing in our catalogue carries a grade whose population names this group specifically. That is worth stating plainly rather than filling the space: what we have is evidence in mixed populations, and applying it here is an assumption.
Browse every graded intervention instead
Reference ranges drift with age, and a value that is "normal for your age" can still be worth acting on. Ask what the range is normalised against before accepting a reassurance.
Which tests matter, and when
Keep the metabolic and lipid panels, but add function: grip strength, gait speed, a sit-to-stand, hearing, and a medication review with a pharmacist or clinician. These predict the next decade better than anything on a blood panel.
No marker in our catalogue has a reference range sliced specifically for this group, so the general ranges apply. See the full range table.